# Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC

> **NCT06896422** · PHASE1 · RECRUITING · sponsor: **The First Affiliated Hospital of Zhengzhou University** · enrollment: 80 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Chemotherapy
- PD1 Antibody
- Glutathione

## Interventions

- **DRUG:** Glutathione
- **DRUG:** PD1 Inhibitor
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06896422
- **Lead sponsor:** The First Affiliated Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06896422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06896422, "Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06896422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*